124 related articles for article (PubMed ID: 8209057)
1. Bronchodilator response to nebulized salbutamol in elderly patients with stable chronic airflow limitation.
Geraghty R; Foster C; Black D; Roe S
Respir Med; 1993 Jul; 87(5):375-8. PubMed ID: 8209057
[TBL] [Abstract][Full Text] [Related]
2. Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.
Cazzola M; Di Perna F; Noschese P; Vinciguerra A; Calderaro F; Girbino G; Matera MG
Eur Respir J; 1998 Jun; 11(6):1337-41. PubMed ID: 9657576
[TBL] [Abstract][Full Text] [Related]
3. Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease.
Hadcroft J; Calverley PM
Thorax; 2001 Sep; 56(9):713-20. PubMed ID: 11514693
[TBL] [Abstract][Full Text] [Related]
4. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
Nisar M; Walshaw M; Earis JE; Pearson MG; Calverley PM
Thorax; 1990 Mar; 45(3):190-4. PubMed ID: 2330551
[TBL] [Abstract][Full Text] [Related]
5. Acute bronchodilator trials in chronic obstructive pulmonary disease.
Nisar M; Earis JE; Pearson MG; Calverley PM
Am Rev Respir Dis; 1992 Sep; 146(3):555-9. PubMed ID: 1387772
[TBL] [Abstract][Full Text] [Related]
6. Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation.
Jenkins SC; Heaton RW; Fulton TJ; Moxham J
Chest; 1987 Jun; 91(6):804-7. PubMed ID: 3556051
[TBL] [Abstract][Full Text] [Related]
7. Nebulized wet aerosol treatment in emergency department--is it essential? Comparison with large spacer device for metered-dose inhaler.
Mandelberg A; Chen E; Noviski N; Priel IE
Chest; 1997 Dec; 112(6):1501-5. PubMed ID: 9404745
[TBL] [Abstract][Full Text] [Related]
8. Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease.
Thomas P; Pugsley JA; Stewart JH
Chest; 1992 Jan; 101(1):160-5. PubMed ID: 1729064
[TBL] [Abstract][Full Text] [Related]
9. Responses of FEV6, FVC, and FET to inhaled bronchodilator in the adult general population.
Kainu A; Lindqvist A; Sarna S; Lundbäck B; Sovijärvi A
Respir Res; 2009 Jul; 10(1):71. PubMed ID: 19638220
[TBL] [Abstract][Full Text] [Related]
10. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease.
Hay JG; Stone P; Carter J; Church S; Eyre-Brook A; Pearson MG; Woodcock AA; Calverley PM
Eur Respir J; 1992 Jun; 5(6):659-64. PubMed ID: 1628722
[TBL] [Abstract][Full Text] [Related]
11. Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease.
Grove A; Lipworth BJ; Reid P; Smith RP; Ramage L; Ingram CG; Jenkins RJ; Winter JH; Dhillon DP
Thorax; 1996 Jul; 51(7):689-93. PubMed ID: 8882074
[TBL] [Abstract][Full Text] [Related]
12. The role of domiciliary nebulizers in managing patients with severe COPD.
Eiser N; Angus K; McHale S
Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
[TBL] [Abstract][Full Text] [Related]
13. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
[TBL] [Abstract][Full Text] [Related]
14. Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation.
Guyatt GH; Townsend M; Nogradi S; Pugsley SO; Keller JL; Newhouse MT
Arch Intern Med; 1988 Sep; 148(9):1949-52. PubMed ID: 3046537
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of two doses of salbutamol nebulized at 4 and 8 litres per minute in patients with chronic asthma.
Douglas JG; Leslie MJ; Crompton GK; Grant IW
Br J Dis Chest; 1986 Jan; 80(1):55-8. PubMed ID: 3947525
[TBL] [Abstract][Full Text] [Related]
16. Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease.
Wempe JB; Postma DS; Breederveld N; Kort E; van der Mark TW; Koëter GH
Thorax; 1992 Aug; 47(8):616-21. PubMed ID: 1412119
[TBL] [Abstract][Full Text] [Related]
17. [Response to inhaled bronchodilators in chronic airway obstruction].
Holten K
Tidsskr Nor Laegeforen; 1993 Feb; 113(4):444-7. PubMed ID: 8465284
[TBL] [Abstract][Full Text] [Related]
18. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ipratropium bromide and albuterol in chronic obstructive pulmonary disease: a three-center study.
Braun SR; Levy SF
Am J Med; 1991 Oct; 91(4A):28S-32S. PubMed ID: 1835292
[TBL] [Abstract][Full Text] [Related]
20. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
Ikeda A; Nishimura K; Koyama H; Izumi T
Chest; 1995 Feb; 107(2):401-5. PubMed ID: 7842768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
